Article
RANKL and RANK in Cancer Therapy
6 Dec 2022
Abstract excerpt
Receptor activator of nuclear factor-κB (RANK) and its ligand (RANKL) are key regulators of mammalian physiology such as bone metabolism, immune tolerance and antitumor immunity, and mammary gland biology. Here, we explore the multiple functions of RANKL/RANK in physiology and pathophysiology and discuss underlying principles and strategies to modulate the RANKL/RANK pathway as a therapeutic target in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
